Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Long-Term Investments (2022 - 2025)

Historic Long-Term Investments for Harmony Biosciences Holdings (HRMY) over the last 4 years, with Q3 2025 value amounting to $105.8 million.

  • Harmony Biosciences Holdings' Long-Term Investments rose 1232.09% to $105.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $105.8 million, marking a year-over-year increase of 1232.09%. This contributed to the annual value of $108.9 million for FY2024, which is 5085.98% up from last year.
  • Per Harmony Biosciences Holdings' latest filing, its Long-Term Investments stood at $105.8 million for Q3 2025, which was up 1232.09% from $107.0 million recorded in Q2 2025.
  • Harmony Biosciences Holdings' Long-Term Investments' 5-year high stood at $108.9 million during Q4 2024, with a 5-year trough of $4.7 million in Q2 2022.
  • Its 4-year average for Long-Term Investments is $69.3 million, with a median of $76.7 million in 2023.
  • As far as peak fluctuations go, Harmony Biosciences Holdings' Long-Term Investments soared by 113553.82% in 2023, and later soared by 1232.09% in 2025.
  • Quarter analysis of 4 years shows Harmony Biosciences Holdings' Long-Term Investments stood at $22.6 million in 2022, then soared by 219.78% to $72.2 million in 2023, then surged by 50.86% to $108.9 million in 2024, then fell by 2.79% to $105.8 million in 2025.
  • Its Long-Term Investments was $105.8 million in Q3 2025, compared to $107.0 million in Q2 2025 and $103.2 million in Q1 2025.